Latest filing published 10 Jun 2026 for 대원제약.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -23.9%Entry ₩10,840 · Close 07 Oct 2026 ₩8,250
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
임한일: trading record in brief
임한일 is a declared insider of 대원제약 (senior executive), with filings sourced from DART (FSS). In total, 4 filings cover trades dated from 10 March 2022 to 10 June 2026.
Both buying and selling appear: 2 purchases worth €18k, against 1 sale. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and 1 sale.
Most recently, on 10 June 2026, the filings show an open-market sale in 대원제약. The latest purchase dates back some time: it was published 240 days ago, on 13 March 2026. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 임한일
Open company profiles for insider transactions, fundamentals and analyst consensus when available.